David Akeroyd
Managing Director, Australia/New Zealand
Baxter is a truly unique organisation, providing a diverse range of products and services for patients all over the world with some of the most critical health care needs.
Our reputation for the quality production of sterile technologies, related to IV therapies, started over 75 years ago.
Today, Baxter continues to innovate and influence medical science via the development of vaccines, biopharmaceuticals and critical therapies for conditions such as cancer, kidney disease and haemophilia.
We are a leader in many of the healthcare markets in which we operate under our divisions of Medication Delivery, Bioscience and Renal and employ more than 1000 Australians and New Zealanders for local production and operations.
We work with governments to ensure the market reflects the true needs of patients and recognise many people within the industry for improving the quality of care delivered via Award programs. Community groups and local charities are also a priority for our sustainability efforts.
What sets us apart is our dedication to ‘making a meaningful difference’. We apply this to our research, recruitment, production, patient services, training, community sponsorships, in fact everything we do.
Australasian medical specialists and researchers use Baxter technologies to make exciting new breakthroughs that have immense potential application, not just locally, but world-wide. However, it is our dedicated and talented employees who provide the care and inspiration that makes Baxter the world-class company it is today. They truly engender the philosophy of making a meaningful difference in the lives of patients.
People and their potential are important to Baxter and we offer a wide range of employee benefits, programmes and training to enhance your skills and future advancement.
As a prospective employee of Baxter, you would be joining a group of individuals who are passionate about their work and the needs of patients, families and the communities in which we operate.
We thank you for your interest in Baxter.